Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05132881 · ClinicalTrials.gov registry record · NA

Effect of (TaVNS) on Anxiety and Brain Function in Distressed Health Care Workers

A NA study of Healthy and Anxiety, sponsored by Thomas Jefferson University.

Active
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT05132881: Active NA study of Healthy and Anxiety, sponsored by Thomas Jefferson University.

NCT05132881 is a NA study of Healthy and Anxiety that is active but no longer recruiting, run by Thomas Jefferson University. The registered enrollment target is 90 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05132881, a NA study of Healthy and Anxiety, is active but no longer recruiting, sponsored by Thomas Jefferson University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to measure alterations in anxiety and brain activity associated with the use of an approved health device called Transauricular Vagal Nerve Stimulation (TaVNS) in distressed persons who work in a health care and distressed healthcare workers in the the Philadelphia, PA region. The Investigators will be using functional magnetic resonance imaging (or fMRI) to measure changes in each subject's brain function during the use of VNS. This study is designed to allow researchers to understand the changes in cerebral (brain) activity that occur when a subject uses VNS. Thus, the primary goal of the proposed study is to evaluate the ability of the TaVNS system to reduce distress and change neurophysiology among health care providers. The Investigators, hypothesize that using the TaVNS device will help reduce distress in individuals. In order to understand the mechanisms of change that occur while using the VNS study, the Investigators have added a substudy of participants who do not experience high levels of distress to evaluate the effects of the functional changes that may occur in the brain while using the TaVNS device. In addition to the primary aims of the overalll study to assess distress in workers while enrolled in a TaVNS program, a subgroup of 50 subjects will undergo functional magnetic resonance imaging (fMRI) while using the VNS device to assess the changes in the brain including neurophysiological effects of TaVNS. The goal of this substudy is to observe the changes in the brain while using the TaVNS earbuds in the MRI to increase our understanding of the mechanisms and processing involved while using TaVNS. In this substudy, which is amendment version 3.0, the investigators have increased the number of persons to include 50 subjects who will use the device in the MRI to evaluate the neural processes and cerebral blood flow while using TaVNS.

Primary Outcome

The Subjective Units of Distress Survey (SUDS) is a way for participants to communicate how much distress they are currently feeling using a 0 to 10 scale with zero corresponding to a relaxed state without distress and ten corresponding to extreme distress filled with panic, tension, fear, and anxiety.

Interventions

  • OTHER Waitlist Control
  • OTHER Neuvana 2.0 Transcutaneous Auricular Vagal Nerve Stimulation (TaVNS)
  • OTHER Healthy Controls: Substudy Group III
  • OTHER Distressed Workers: Subgroup II

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University, Marcus Institute of Integrative Health Centers - Philadelphia

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2021-04-01
Est. Completion 2025-11-20
Phase NA
Thomas Jefferson University

292 total trials

What the registry record for NCT05132881 still lists

NCT05132881 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (86% lower).

The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Waitlist Control is the first listed.

NCT05132881 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05132881 about?

NCT05132881 is a clinical study titled "Effect of (TaVNS) on Anxiety and Brain Function in Distressed Health Care Workers". The purpose of this research is to measure alterations in anxiety and brain activity associated with the use of an approved health device called Transauricular Vagal Nerve Stimulation (TaVNS) in distressed persons who work in a health care and distressed healthcare workers in the the Philadelphia, P...

What is the current status of trial NCT05132881?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2021-04-01. Estimated completion is 2025-11-20.

What conditions does trial NCT05132881 study?

This clinical trial studies the following conditions: Healthy, Anxiety, Distress, Emotional, Effects of Vibration.

What interventions are being tested in trial NCT05132881?

The interventions under investigation include: Waitlist Control (OTHER), Neuvana 2.0 Transcutaneous Auricular Vagal Nerve Stimulation (TaVNS) (OTHER), Healthy Controls: Substudy Group III (OTHER), Distressed Workers: Subgroup II (OTHER).

Who is sponsoring clinical trial NCT05132881?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05132881 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05132881's enrollment target sits among peer trials

90 252nd of 1090 higher than 833 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05132881, the US trial registry maintained by the National Library of Medicine. NCT05132881 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.